Literature DB >> 7252334

Depression of phagocytosis by plasmin degradation products of plasma fibronectin.

M I Ehrlich, J S Krushell, F A Blumenstock, J E Kaplan.   

Abstract

Previous research has shown that disseminated intravascular coagulation causes a depression in RE function. Fibronectin, a high-molecular-weight surface-binding glycoprotein, is known to modulate RE function by facilitating opsonic activity and is sensitive to proteolytic cleavage by plasmin, yielding FNDP. The present investigation suggests that isolated FNDP, generated in vitro by incubation with plasmin, can depress phagocytosis in vivo as well as in vitro. Phagocytosis in rats was determined by a clearance technique employing CR51-RBCs and in vitro by employing a monolayer of peritoneal exudate macrophages. The in vivo studies demonstrated significantly reduced hepatic phagocytosis after the injection of FNDP an delayed clearance of injected test particles. Macrophage uptake in vitro, supported by either normal rat serum or purified fibronectin, was significantly reduced when incubated with FNDP. These results suggest that depression of the RE system and phagocytosis during intravascular coagulation may be mediated in part by the formation of plasmin degradation products of plasma fibronectin.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7252334

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  10 in total

1.  Plasma fibronectin concentrations in blood products.

Authors:  J Perttilä; M Salo; O Peltola
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

Review 2.  Fibronectin and phagocytosis.

Authors:  H Hörmann
Journal:  Blut       Date:  1985-11

Review 3.  Macrophage functions in antimicrobial defense.

Authors:  T Schaffner; H U Keller; M W Hess; H Cottier
Journal:  Klin Wochenschr       Date:  1982-07-15

4.  Disseminated intravascular coagulation (DIC) induced by liquoid (polyanetholsulfonate) in the rat. V. Effects on circulating fibronectin.

Authors:  J Cerda; R E Urizar; R Conran; F A Blumenstock; J E Kaplan; A B Malik; R Simon
Journal:  Br J Exp Pathol       Date:  1986-10

5.  Fibronectin and Kupffer cell function in fulminant hepatic failure.

Authors:  M Imawari; R D Hughes; C D Gove; R Williams
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

Review 6.  Plasma fibronectin: relevance for anesthesiology and intensive care.

Authors:  J E Doran; P Lundsgaard-Hansen; E Rubli
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

7.  Role of fibronectin in human monocyte and macrophage bactericidal activity.

Authors:  R A Proctor; J A Textor; J M Vann; D F Mosher
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

8.  Modulation of human neutrophil function by fibronectin degradation products isolated from cryoglobulins.

Authors:  F Morel; L C Cholley; A C Dianoux; J C Renversez; D Anthony; C Revol; F Boulay; J Gagnon; P V Vignais
Journal:  Inflammation       Date:  1992-08       Impact factor: 4.092

9.  Reversal of fibronectin and opsonic deficiency in patients. A controlled study.

Authors:  T M Saba; F A Blumenstock; D M Shah; J E Kaplan; E Cho; W Scovill; H Stratton; J Newell; M Gottlieb; N Sedransk
Journal:  Ann Surg       Date:  1984-01       Impact factor: 12.969

10.  [Fibronectin].

Authors:  E Klar; D L Heene
Journal:  Klin Wochenschr       Date:  1984-10-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.